SALLIE BOOTH: Open Payments
NPI 1578285854 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 11 payments from 10 companies in 2025. Trend: 2023 $1,182 · 2024 $649 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
| Geron Corporation | 1 | $19 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $15 |
Products named: Fabhalta, TAGRISSO, Trodelvy, CARVYKTI, ULTOMIRIS, Venclexta, RYTELO, NERLYNX.
Industry payments across TN — which companies pay providers there.
